Cited by — Metastatic metaplastic triple negative breast cancer response to sacituzumab govitecan and biomarker targetability | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Metastatic metaplastic triple negative breast cancer response to sacituzumab govitecan and biomarker targetability.
No admitted local citation edges point to this work yet.
